The table below shows Inhibrx, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2024
Q3 2023
Q2 2023
Q1 2023
Q3 2022
Q2 2022
Revenue
$0.00
$119.00K
$30.00K
$17.00K
$278.00K
$711.00K
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$63.85M
$38.06M
$34.11M
$37.39M
$24.93M
$29.91M
SG&A
INBX annual revenue (10-K history)
Inhibrx, Inc. reported annual revenue of $1.80M for fiscal year 2023. That is down 17.9% from $2.19M in fiscal 2022. Over the 5 fiscal years shown, annual revenue declined from $13.21M (FY 2019) to $1.80M. Figures come from the company's audited annual reports as filed with the SEC.